195 related articles for article (PubMed ID: 32928967)
1. Association between
Lee JS; Lee H; Park S; Choe Y; Park YH; Cheon BK; Hahn A; Ossenkoppele R; Kim HJ; Kim S; Yoo H; Jang H; Cho SH; Kim SJ; Kim JP; Jung YH; Park KC; DeCarli C; Weiner MW; Na DL; Seo SW
Neurology; 2020 Oct; 95(17):e2354-e2365. PubMed ID: 32928967
[TBL] [Abstract][Full Text] [Related]
2. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
3. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cerebrovascular Disease in Amyloid Deposition.
Noh Y; Seo SW; Jeon S; Lee JM; Kim JS; Lee JH; Kim JH; Kim GH; Ye BS; Cho H; Kim HJ; Yoon CW; Choe YS; Lee KH; Weiner MW; Na DL
J Alzheimers Dis; 2016 Oct; 54(3):1015-1026. PubMed ID: 27567803
[TBL] [Abstract][Full Text] [Related]
5. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.
Kim HJ; Park S; Cho H; Jang YK; San Lee J; Jang H; Kim Y; Kim KW; Ryu YH; Choi JY; Moon SH; Weiner MW; Jagust WJ; Rabinovici GD; DeCarli C; Lyoo CH; Na DL; Seo SW
JAMA Neurol; 2018 Aug; 75(8):999-1007. PubMed ID: 29799981
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.
Jang H; Kim HJ; Park S; Park YH; Choe Y; Cho H; Lyoo CH; Yoon U; Lee JS; Kim Y; Kim SJ; Kim JP; Jung YH; Ryu YH; Choi JY; Moon SH; Seong JK; DeCarli C; Weiner MW; Lockhart SN; Cho SH; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):292-303. PubMed ID: 31471715
[TBL] [Abstract][Full Text] [Related]
9. Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.
Kim HJ; Ye BS; Yoon CW; Cho H; Noh Y; Kim GH; Choi YS; Kim JH; Jeon S; Lee JM; Kim JS; Choe YS; Lee KH; Kim ST; Kim C; Kang DR; Ki CS; Lee JH; Werring DJ; Weiner MW; Na DL; Seo SW
Neurobiol Aging; 2013 Nov; 34(11):2482-7. PubMed ID: 23769398
[TBL] [Abstract][Full Text] [Related]
10. Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment.
Liu X; Zeng Q; Luo X; Li K; Xu X; Hong L; Li J; Guan X; Xu X; Huang P; Zhang MM;
CNS Neurosci Ther; 2023 Feb; 29(2):597-608. PubMed ID: 36468416
[TBL] [Abstract][Full Text] [Related]
11. Clinical phenotype, atrophy, and small vessel disease in
Groot C; Sudre CH; Barkhof F; Teunissen CE; van Berckel BNM; Seo SW; Ourselin S; Scheltens P; Cardoso MJ; van der Flier WM; Ossenkoppele R
Neurology; 2018 Nov; 91(20):e1851-e1859. PubMed ID: 30341156
[TBL] [Abstract][Full Text] [Related]
12. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
13. Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment.
Kim HR; Jung SH; Kim B; Kim J; Jang H; Kim JP; Kim SY; Na DL; Kim HJ; Nho K; Won HH; Seo SW
Front Aging Neurosci; 2023; 15():1160536. PubMed ID: 37143691
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Amyloid Positivity in Patients with Subcortical Vascular Cognitive Impairment.
Moon H; Ham H; Yun J; Shin D; Lee EH; Kim HJ; Seo SW; Na DL; Jang H
J Alzheimers Dis; 2024; 99(3):1117-1127. PubMed ID: 38788077
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
16. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
[TBL] [Abstract][Full Text] [Related]
17. Association between apolipoprotein E gene polymorphism and mild cognitive impairment: a meta-analysis.
Jiang Y; He T; Deng W; Sun P
Clin Interv Aging; 2017; 12():1941-1949. PubMed ID: 29180857
[TBL] [Abstract][Full Text] [Related]
18.
Lim YY; Mormino EC;
Neurology; 2017 Sep; 89(10):1028-1034. PubMed ID: 28794245
[TBL] [Abstract][Full Text] [Related]
19. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
20. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.
Lemmens R; Görner A; Schrooten M; Thijs V
Stroke; 2007 Apr; 38(4):1185-8. PubMed ID: 17322072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
